PharmiWeb.com - Global Pharma News & Resources

Akari Therapeutics

Research & Development

Akari Therapeutics was established in 2005 in the UK. We develop life-transforming treatments for autoinflammatory diseases involving the complement (C5) and leukotriene (LTB4) pathways.